AI Drug Discovery Targets the Factory Floor
A new joint venture is shifting AI’s role from designing molecules to actually building them at scale.
July 17, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🧪 Drug Discovery.
Chai Discovery Hits Three Billion Dollar Valuation
A massive new funding round for an AI drug startup shows that Big Pharma is outsourcing its most critical early-stage molecular design.
July 14, 2026
Turning Failed Clinical Trials Into AI Models
Biotech companies are finding a second life for failed drug data, but recycling bad trials into predictive algorithms carries hidden risks.
July 12, 2026
AI agent runs biomedical research tasks autonomously
A new AI agent named Biomni can design and run its own lab experiments, shifting the bottleneck of medical discovery from human labor to machine execution.
July 10, 2026
Pharma Regulatory AI Draws Ninety-Five Million Dollars
A massive influx of capital into clinical trial automation signals that the next high-value AI frontier is boring paperwork.
July 8, 2026
Can AI fix the drug development bottleneck?
A new UK regulatory initiative is putting AI to the test to solve the pharmaceutical industry’s most expensive problem: high failure rates.
July 8, 2026
Digital Twins Solve Rare Disease Trial Dilemma
Using virtual clones to simulate disease progression could finally solve the recruitment bottleneck that stalls rare disease drug development.
July 5, 2026
Anthropic Launches Claude Science for Drug Discovery
An AI giant is moving from writing software code to designing biological molecules, raising both commercial hopes and biosecurity alarms.
June 30, 2026
Mirror-image proteins could end drug injections
By rebuilding proteins backward, drug developers are trying to bypass the human digestive system’s natural defenses.
June 26, 2026
Testing Drugs Without the Animals
Regulators are finally letting AI predict drug safety before human trials, signaling a massive shift away from traditional animal testing.
June 19, 2026